Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis

Annunziata Dattola; Arianna Zangrilli; Luca Bianchi

doi:10.5826/dpc.1104a100

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis

Authors

Annunziata Dattola Department of Dermatology University of Rome “Tor Vergata”, Rome, Italy
Arianna Zangrilli Department of Dermatology University of Rome “Tor Vergata”, Rome, Italy
Luca Bianchi Department of Dermatology University of Rome “Tor Vergata”, Rome, Italy

Keywords:

guttate psoriasis, plaque psoriasis, risankizumab, renal disease

References

Fang R, Sun Q. Guttate Psoriasis. Indian Pediatr. 2020;57(6):596-597. DOI: 10.1007/s13312-020-1880-0. PMID: 32562412.

Shalanda L. Hall, Wasim Haidari, Steven R. Feldman. Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab. J Drugs Dermatol. 2019;18(8):822-823.

Dattola A, Silvestri M, Tamburi F, Amoruso GF, Bennardo L, Nisticò SP. Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising. Dermatol Ther. 2020:e14504. DOI: 10.1111/dth.14504.

Downloads

Published

2021-10-29

Issue

2021 Vol 11, No 4 | October

Section

Letter

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

Dattola A, Zangrilli A, Bianchi L. Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis. Dermatol Pract Concept. Published online October 29, 2021:e2021100. doi:10.5826/dpc.1104a100